Pentwater Capital Management’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-12,898
| Closed | -$953K | – | 162 |
|
|
2021
Q3 | $953K | Sell |
12,898
-102
| -0.8% | -$7.54K | 0.01% | 152 |
|
|
2021
Q2 | $711K | Buy |
13,000
+3,000
| +30% | +$164K | 0.01% | 188 |
|
|
2021
Q1 | $737K | Buy |
10,000
+2,000
| +25% | +$147K | 0.01% | 190 |
|
|
2020
Q4 | $690K | Sell |
8,000
-11,900
| -60% | -$1.03M | 0.01% | 142 |
|
|
2020
Q3 | $751K | Buy |
+19,900
| New | +$751K | 0.01% | 138 |
|